1. Switzerland Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Sonova Holding AG

Sonova Holding AG

SOON.SW
Sonova Holding AGCH flagSwiss Exchange
207.40
CHF
+3.80
- -
12.32BMarket Cap
Sonova Holding AG
SOON.SW
(Swiss Exchange)

Recent

price

207.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
121.56
121.02
133.76
28.88
30.14
31.21
36.43
40.24
42.19
45.62
41.32
54.02
62.07
60.82
60.62
60.53
Revenue per Share
17.37
18.44
8.18
5.04
5.33
5.08
5.31
6.08
6.93
7.56
9.23
10.42
10.75
10.08
9.07
7.23
Basic EPS, GAAP
17.52
16.75
22.71
4.68
5.49
5.2
6.45
7.96
8.14
11.18
10.72
13.4
10.45
10.48
11.05
10.61
Free Cash Flow per Basic Share
5.97
5.97
5.95
1.59
1.89
2.05
2.09
2.29
2.59
2.92
- -
3.24
4.44
4.6
4.3
4.4
Dividend per Share
92.12
110.3
119.47
25.76
28.38
30.7
32.25
37.29
38.49
38.46
48.51
50.29
43.86
41.49
44.8
44.64
Book Value per Share
21.48
26.91
32.89
9.08
9.66
8.38
-2.92
0.13
-1.33
-6.11
5.57
-8.29
-13.73
-9.18
-5.03
0.25
Tangible Book Value per Share
13
13
13
68
68
66
66
66
66
64
63
62
60
60
60
60
Basic Weighted Avg Shares
1,617
1,620
1,795
1,951
2,035
2,072
2,396
2,646
2,763
2,917
2,602
3,364
3,738
3,627
3,613
3,606
Sales/Revenue/Turnover
18.95
18.22
8.66
20.71
21.08
19.05
17.69
18.05
19.39
17.48
19.03
22.6
19.98
18.47
19.92
18.74
Operating Margin (%)
103
78
82
83
85
89
147
135
128
200
223
211
240
246
233
260
Depreciation Expense
231
247
110
341
360
337
349
400
454
483
581
649
648
601
540
431
Net Income, GAAP
11.16
12.55
25.32
11.96
12.37
12.9
14.65
14.93
13.1
2.57
2.53
8.86
8.02
5.84
17.45
14.91
Effective Tax Rate (%)
14.29
15.23
6.11
17.47
17.69
16.27
14.58
15.12
16.43
16.57
22.33
19.29
17.32
16.57
14.96
11.94
Profit Margin (%)
278
341
615
507
569
499
532
582
282
118
1,368
154
409
514
411
895
Working Capital
228
242
229
- -
- -
- -
759
609
360
767
1,410
1,080
1,736
1,715
1,328
1,525
LT Debt
1,345
1,481
1,641
1,774
1,872
1,906
2,131
2,475
2,376
2,029
2,772
2,433
2,231
2,491
2,685
2,636
Total Equity
15.77
14.84
6.26
18.75
19.59
17.53
14.58
12.85
14.48
15.83
12.23
15.81
16.65
14.57
13.11
12.73
Return on Invested Capital (%)
14.48
15.6
6.29
18.38
18.68
16.45
13.84
12.85
14.09
14.46
14.06
13.69
14.45
14.13
12.73
10.09
Return on Capital (%)
18.91
18.27
7.13
20.38
19.69
17.05
16.79
17.5
18.26
19.41
21.08
20.98
22.43
23.5
21.01
16.16
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.3%
-0.59%
-1.81%
Free Cash Flow
7.62%
-0.08%
-4.07%
Net Income, GAAP
3.22%
-5.22%
-20.33%
Sales/Revenue/Turnover
6.21%
7.37%
-0.19%
Total Cash Common Dividend
10,066.44%
20,146.2%
2.38%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3,627
2025
- -
- -
- -
- -
3,613
2026
- -
- -
- -
- -
3,606

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
10.08
2025
- -
- -
- -
- -
9.07
2026
- -
- -
- -
- -
7.23

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4.6
2025
- -
- -
- -
- -
4.3
2026
- -
- -
- -
- -
4.4
Similar Companies
Bluejay Diagnostics, Inc. (BJDX)
SciBase Holding AB (publ) (SCIB.ST)
RUA Life Sciences plc (RUA.L)
Sinocare Inc. (300298.SZ)
Hancock Jaffe Laboratories, Inc. Warrants (HJLIW)
Medistim ASA (0OCD.L)
Business
Sonova Holding AG develops, manufactures, and distributes hearing care solutions worldwide. The company offers a broad portfolio of hearing instruments under the Phonak brand, including advanced receiver-in-canal (RIC), behind-the-ear (BTE), and in-the-ear (ITE) models equipped with features such as adaptive noise reduction, speech enhancement, and Bluetooth connectivity; cochlear implants and accessories via the Advanced Bionics brand; wireless communication systems and streamers for Phonak and Roger brands; and consumer hearing aids through the Sennheiser (formerly branded as hearX by Sennheiser) and AudioNova lines. It also provides audiological services through a network of retail clinics under the AudioNova, Boots Hearingcare, and Connect Hearing banners, serving private customers, wholesalers, and public health systems. Sonova Holding AG operates in over 100 countries, with principal manufacturing facilities in Switzerland, the United States, China, and Mexico, and its global retail presence spanning Europe, North America, and Asia-Pacific. Founded in 1947 and headquartered in Stäfa, Switzerland, the company focuses on the hearing care industry segments of prescription devices, retail services, and consumer audio solutions, targeting individuals with hearing loss, audiologists, and healthcare providers. In recent developments, Sonova completed the acquisition of Sennheiser Consumer Division in early 2025, enhancing its over-the-counter hearing aid offerings and integrating the hearX technology platform for direct-to-consumer sales. The company announced a strategic partnership with Amazon in mid-2025 to expand distribution of OTC hearing aids via online marketplaces, alongside launching the Phonak Lumity platform update with AI-driven sound processing improvements. Additionally, Sonova secured a CHF 500 million funding facility in Q3 2025 to support expansion into emerging markets in Asia and Latin America.